Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
GetHarley, a skincare telehealth and consultation platform, raises $52M

From TechCrunch

By Paul Sawers

June 6, 2023

GetHarley, a skincare telehealth and consultation platform, raises $52M

GetHarley, a skincare telehealth and consultation platform, raises $52M

GetHarley, a platform that connects consumers with skincare clinicians and related products, has raised $52 million in a round of funding led by existing investor Index Ventures.

Founded out of London in 2019 by Charmaine Chow, GetHarley is a telehealth platform that gives anyone a direct channel to qualified skincare professionals, including dermatologists and plastic surgeons, who recommend products and treatments for conditions such as acne, uneven skin tone or hyperpigmentation, rosacea, melasma and more. Online consultations cost £40 ($50) for 30 minutes, though where more complex medical histories are involved, patients can pay £150 ($186) for a more senior-level consultant dermatologist.

Part of GetHarley’s business model involves selling skincare products as part of a personalized plan, catering to specific individual factors such as whether the individual has dry or oily skin, or how light / dark their skin is. Products may include anything from cleansers and serums to moisturizers and eye creams.

GetHarley box

GetHarley box. Image Credits: GetHarley

Skin in the game

The broader global skincare products market was pegged as a $130 billion industry in 2021, however, GetHarley positions itself in a narrower niche categorized as “medical-grade skincare” or “cosmeceuticals” as they’re sometimes called. These are sort of hybrids between cosmetics and pharmaceuticals, formulated with a “higher concentration of active ingredients” than what you might find in a store and are often only available through clinicians. This was estimated as a $45 billion industry in 2021.

The skincare market size has been a boon for skincare startups too, with LA-based Topicals and Mother Science, and Kenya’s Uncover, all raising venture capital (VC) cash in recent months to expand their own-brand skincare products.

GetHarley is taking a slightly different approach, instead curating established products and using qualified clinicians to recommend specific plans. With thousands of products on the market, many with their own unique pitch on why they are the best thing since sliced bread, it’s difficult to filter through the noise — GetHarley promises to make things a little easier.

“The skincare industry is overflowing with false claims, celebrity marketing and thousands upon thousands of choices about how to care for your skin,” Chow said in a press release. “You end up wasting huge amounts of time, money and energy trying to figure out what works for you. I should know — I looked everywhere for solutions for my challenging skin. And while consumers are being pulled in multiple directions, clinicians are time-poor and overstretched and you can never quite get hold of them. GetHarley solves all this, giving experts a one-stop platform, and helping global consumers get access to the best advice in a crowded marketplace.”

Prior to now, GetHarley had raised around $15 million in funding, and in the four years since its foundation, the company says it has garnered some 100,000 active users and amassed a team of 70 — a figure it expects to double over the next year.

In addition to lead backer Index, GetHarley’s latest funding round included participation from Headline, Visionaries Club and Village Global.

GetHarley, a skincare telehealth and consultation platform, raises $52M by Paul Sawers originally published on TechCrunch

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

GlossGenius raises $28M to expand its bookings and payments platform for beauty businesses

GlossGenius raises $28M to expand its bookings and payments platform for beauty businesses

GlossGenius, a platform designed to handle bookings and payments for salons and spas, today announced that it raised $28 million in a Series C funding round led by L Catterton with participation from Bessemer Venture Partners and Imaginary Ventures. The round values GlossGenius at $510 million — the startup’s second up-round in the past 12 […]

Jul 27, 2023

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a four-year-old German startup that combines a digital healthcare platform with real-world brick-and-mortar clinics, has raised €100 million ($108 million) in a Series C round of funding led by Israeli VC firm Pitango, constituting a mix of equity and debt. Founded out of Berlin in 2019, Patient21’s platform spans pretty much the whole patient […]

May 21, 2023

Musely secures $360M from General Catalyst without giving up equity

Musely secures $360M from General Catalyst without giving up equity

The DTC skin, hair, and menopause care brand will use the non-dilutive capital to super-charge customer acquisition.

May 1, 2026

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

HealthPlix, an Indian startup offering its in-house platform for doctors to help record patient data digitally, has raised $22 million in fresh investment to broaden its reach in the country and allow more doctors to utilize its software to offer improved care to their patients. In India, roughly 300,000 doctors practice medicine regularly. However, this […]

Mar 14, 2023

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

GlossGenius raises $28M to expand its bookings and payments platform for beauty businesses

GlossGenius raises $28M to expand its bookings and payments platform for beauty businesses

GlossGenius, a platform designed to handle bookings and payments for salons and spas, today announced that it raised $28 million in a Series C funding round led by L Catterton with participation from Bessemer Venture Partners and Imaginary Ventures. The round values GlossGenius at $510 million — the startup’s second up-round in the past 12 […]

Jul 27, 2023

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a four-year-old German startup that combines a digital healthcare platform with real-world brick-and-mortar clinics, has raised €100 million ($108 million) in a Series C round of funding led by Israeli VC firm Pitango, constituting a mix of equity and debt. Founded out of Berlin in 2019, Patient21’s platform spans pretty much the whole patient […]

May 21, 2023

Musely secures $360M from General Catalyst without giving up equity

Musely secures $360M from General Catalyst without giving up equity

The DTC skin, hair, and menopause care brand will use the non-dilutive capital to super-charge customer acquisition.

May 1, 2026

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

HealthPlix, an Indian startup offering its in-house platform for doctors to help record patient data digitally, has raised $22 million in fresh investment to broaden its reach in the country and allow more doctors to utilize its software to offer improved care to their patients. In India, roughly 300,000 doctors practice medicine regularly. However, this […]

Mar 14, 2023